» Articles » PMID: 37625853

Biochemical Characterization of MRNA Capping Enzyme from Faustovirus

Overview
Journal RNA
Specialty Molecular Biology
Date 2023 Aug 25
PMID 37625853
Authors
Affiliations
Soon will be listed here.
Abstract

The mammalian mRNA 5' cap structures play important roles in cellular processes such as nuclear export, efficient translation, and evading cellular innate immune surveillance and regulating 5'-mediated mRNA turnover. Hence, installation of the proper 5' cap is crucial in therapeutic applications of synthetic mRNA. The core 5' cap structure, Cap-0, is generated by three sequential enzymatic activities: RNA 5' triphosphatase, RNA guanylyltransferase, and cap N7-guanine methyltransferase. Vaccinia virus RNA capping enzyme (VCE) is a heterodimeric enzyme that has been widely used in synthetic mRNA research and manufacturing. The large subunit of VCE D1R exhibits a modular structure where each of the three structural domains possesses one of the three enzyme activities, whereas the small subunit D12L is required to activate the N7-guanine methyltransferase activity. Here, we report the characterization of a single-subunit RNA capping enzyme from an amoeba giant virus. Faustovirus RNA capping enzyme (FCE) exhibits a modular array of catalytic domains in common with VCE and is highly efficient in generating the Cap-0 structure without an activation subunit. Phylogenetic analysis suggests that FCE and VCE are descended from a common ancestral capping enzyme. We found that compared to VCE, FCE exhibits higher specific activity, higher activity toward RNA containing secondary structures and a free 5' end, and a broader temperature range, properties favorable for synthetic mRNA manufacturing workflows.

Citing Articles

A comparative exploration of mRNA capping enzymes.

Wang Y, Wang X, Li W, Chen X, Lu Y Biotechnol Notes. 2024; 5:165-172.

PMID: 39649099 PMC: 11625350. DOI: 10.1016/j.biotno.2024.11.005.


High-throughput Kinetics using capillary Electrophoresis and Robotics (HiKER) platform used to study T7, T3, and Sp6 RNA polymerase misincorporation.

Carter Z, OBrien W, Lund S, Gardner A PLoS One. 2024; 19(12):e0312743.

PMID: 39621686 PMC: 11611218. DOI: 10.1371/journal.pone.0312743.


Therapeutic synthetic and natural materials for immunoengineering.

Slezak A, Chang K, Hossainy S, Mansurov A, Rowan S, Hubbell J Chem Soc Rev. 2024; 53(4):1789-1822.

PMID: 38170619 PMC: 11557218. DOI: 10.1039/d3cs00805c.

References
1.
Fujimura T, Esteban R . Cap snatching of yeast L-A double-stranded RNA virus can operate in trans and requires viral polymerase actively engaging in transcription. J Biol Chem. 2012; 287(16):12797-804. PMC: 3340004. DOI: 10.1074/jbc.M111.327676. View

2.
Hsu J, Yeh J, Lin T, Li M, Wu M, Hsieh C . Identification of BPR3P0128 as an inhibitor of cap-snatching activities of influenza virus. Antimicrob Agents Chemother. 2011; 56(2):647-57. PMC: 3264257. DOI: 10.1128/AAC.00125-11. View

3.
Dolgin E . The tangled history of mRNA vaccines. Nature. 2021; 597(7876):318-324. DOI: 10.1038/d41586-021-02483-w. View

4.
Vlatkovic I, Ludwig J, Boros G, Szabo G, Reichert J, Buff M . Ribozyme Assays to Quantify the Capping Efficiency of In Vitro-Transcribed mRNA. Pharmaceutics. 2022; 14(2). PMC: 8879150. DOI: 10.3390/pharmaceutics14020328. View

5.
Allen M, Forster T, Schroeder D, Hall M, Roy D, Ghazal P . Locus-specific gene expression pattern suggests a unique propagation strategy for a giant algal virus. J Virol. 2006; 80(15):7699-705. PMC: 1563701. DOI: 10.1128/JVI.00491-06. View